I've been through the expedited designations quite a few times and done the deeper dive backgounding to assess the details -- and it's involved and intensive -- and the different designations come in an escalated scale of requirements...
https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies
and that's where the Healey and Berry connections are vitally important - Herb Brinkman /Sabrina Paganoni as well - e.g.
- taking steps to ensure that the design of the clinical trials is as efficient as practicable, when scientifically appropriate, such as by minimizing the number of patients exposed to a potentially less efficacious treatment
We seem to meet the requirements.
- assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the cross-discipline members of the review team (i.e., clinical, pharmacology-toxicology, chemistry, manufacturing and control, compliance) for coordinated internal interactions and communications with the sponsor through the review division’s Regulatory Health Project Manager
- involving senior managers and experienced review staff, as appropriate, in a collaborative, cross-disciplinary review
And we have the right people in place.
Ice
- Forums
- ASX - By Stock
- PAA
- Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-267
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 140000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 0.170 |
5 | 157060 | 0.165 |
9 | 476304 | 0.160 |
6 | 336734 | 0.155 |
8 | 225333 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 140000 | 3 |
0.185 | 427553 | 5 |
0.190 | 720215 | 6 |
0.195 | 752882 | 12 |
0.200 | 297726 | 10 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |